APA (7th ed.) Citation

A, C., MG, A., P, G., RP, P., R, P., A, L., . . . M, R. (2026). Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies. Blood, 147(16), 1842. https://doi.org/10.1182/blood.2025031409

Chicago Style (17th ed.) Citation

A, Carturan, et al. "Harnessing the CD2 Axis to Broaden and Enhance the Efficacy of CAR T-cell Therapies." Blood 147, no. 16 (2026): 1842. https://doi.org/10.1182/blood.2025031409.

MLA (9th ed.) Citation

A, Carturan, et al. "Harnessing the CD2 Axis to Broaden and Enhance the Efficacy of CAR T-cell Therapies." Blood, vol. 147, no. 16, 2026, p. 1842, https://doi.org/10.1182/blood.2025031409.